Ambidexterity's influence on export strategy development—The case of the Indian pharmaceutical industry
Open Access
- 15 May 2022
- journal article
- research article
- Published by Wiley in Thunderbird International Business Review
- Vol. 64 (5) , 465-476
Abstract
This study investigates the influence that business ambidexterity of the Indian pharmaceutical industry can exert on exports, after the evolution from producer—often with the support of foreign direct investments (FDIs)—to researcher. The growth rate of the sector has changed pace with the introduction of new rules regarding patents, impelling pharma enterprises to invest in research and development (R&D), also for the peculiar category of AYUSH. However, many aspects of this industrial evolution are, if anything, under researched. To fill this gap in knowledge, this research adopts a quantitative methodology on secondary data to investigate the effects and potentialities of ambidexterity, providing evidence from descriptive and inferential statistics. Insisting on traditional production of generics (exploitation) and investing in R&D (exploration) have been coherent with the rise in exports, but several factors still impede the development of the commercial potential of the Indian pharmaceutical industry, mostly due to low per capita health care spending, absence of reliable infrastructure, and severe market competition.Keywords
This publication has 60 references indexed in Scilit:
- Strategic reflexivity in the hotel industry - a value-based analysisWorld Review of Entrepreneurship, Management and Sustainable Development, 2014
- I have a dream: Ayuvayur PharmaceuticalsEmerald Emerging Markets Case Studies, 2013
- The exploration activity's added value into the innovation processGlobal Business and Economics Review, 2013
- Research on management issues in the pharmaceutical industry: a literature reviewInternational Journal of Pharmaceutical and Healthcare Marketing, 2012
- Transcending innovativeness towards strategic reflexivityQualitative Market Research: An International Journal, 2012
- Pharmaceutical innovation and generic challenge: recent trends and causal factorsInternational Journal of Pharmaceutical and Healthcare Marketing, 2010
- The emergence of the pharmaceutical industry in the developing world and its implications for multinational enterprise strategiesInternational Journal of Pharmaceutical and Healthcare Marketing, 2008
- Exploitative and Explorative Learning as a Response to the TRIPS Agreement in Indian Pharmaceutical FirmsIndustry and Innovation, 2008
- Technology transfer perspectives in globalising India (drugs and pharmaceuticals and biotechnology)The Journal of Technology Transfer, 2007
- The outsourcing of R&D through acquisitions in the pharmaceutical industryJournal of Financial Economics, 2006